All molecular subtypes of glioblastoma are driven by the gain-of-function of receptor tyrosine kinases (RTKs) and/or the loss of tumour suppressor activities (including PTEN, TP53, NF1 and CDKN2a) [3]. The gene discussed is NTRK1; the disease is neoplasm.